SRCL Stericycle
- 46.540
- -0.020-0.04%
- 46.540
- 0.0000.00%
Stericycle News
Tom Gayner's Strategic Moves in Q1 2024: A Deep Dive Into Stericycle Inc's Significant Reduction
Is There An Opportunity With Stericycle, Inc.'s (NASDAQ:SRCL) 49% Undervaluation?
Key Insights Stericycle's estimated fair value is US$88.57 based on 2 Stage Free Cash Flow to Equity Stericycle is estimated to be 49% undervalued based on current share price of US$44.80 Analyst
Stericycle to Participate in Oppenheimer 19th Annual Industrial Growth Conference in May
BANNOCKBURN, Ill., April 30, 2024 (GLOBE NEWSWIRE) -- Stericycle, Inc. (NASDAQ:SRCL) today announced that Ritu Narula, Vice President Treasury, and Andrew Ellis, Senior Vice President Finance, will participate in
Stericycle to Participate in Stifel 2024 Investor Summit at WasteExpo in May
BANNOCKBURN, Ill., April 30, 2024 (GLOBE NEWSWIRE) -- Stericycle, Inc. (NASDAQ:SRCL) today announced that Cindy J. Miller, Chief Executive Officer, and Janet Zelenka, Chief Financial Officer and Chief Information
Stericycle Analysis: Hold Rating Affirmed Amid Revenue Challenges and Cost-Saving Efforts
Stericycle Is Maintained at Hold by Truist Securities
Stericycle Is Maintained at Hold by Truist Securities
Truist Securities: Maintaining Stericycle (SRCL.US) rating, adjusted from holding to holding rating, and adjusted target price from $57.00 to $50.00.
Truist Securities: Maintaining Stericycle (SRCL.US) rating, adjusted from holding to holding rating, and adjusted target price from $57.00 to $50.00.
Truist Securities Maintains Hold on Stericycle, Lowers Price Target to $50
Truist Securities analyst Tobey Sommer maintains Stericycle (NASDAQ:SRCL) with a Hold and lowers the price target from $57 to $50.
Automated Drug Kiosk Market Report 2024: Global Trends, Forecasts and Competitive Analysis to 2030 Featuring MedAvail, Smart RX Systems, Medifriend, Stericycle, Omnicell, ScriptPro, & PickPoint
Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Graco (GGG), Stericycle (SRCL) and Delta Air Lines (DAL)
Oppenheimer Sticks to Their Hold Rating for Stericycle (SRCL)
Stericycle, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
Truist Securities Cuts Stericycle's Price Target to $50 From $57, Hold Rating Maintained
Truist Securities Cuts Stericycle's Price Target to $50 From $57, Hold Rating Maintained.
Earnings Call Summary | Stericycle(SRCL.US) Q1 2024 Earnings Conference
The following is a summary of the Stericycle, Inc. (SRCL) Q1 2024 Earnings Call Transcript:Financial Performance:Stericycle reported Q1 adjusted earnings per share of $0.57, up by $0.08 from Q1 2023,
Stericycle Is Maintained at Neutral by Baird
Stericycle Is Maintained at Neutral by Baird
Baird Maintains Neutral on Stericycle, Lowers Price Target to $55
Baird analyst David Manthey maintains Stericycle with a Neutral and lowers the price target from $62 to $55.
Stericycle Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/26/2024 18.25% Baird $62 → $55 Maintains Neutral 03/07/2024 48.36% RBC Capital → $69 Reiterates Outperf
Analysts Offer Insights on Industrial Goods Companies: Stericycle (SRCL) and A. O. Smith Corporation (AOS)
Stericycle First Quarter 2024 Earnings: Misses Expectations
RBC Capital Keeps Their Buy Rating on Stericycle (SRCL)
Analysis
Price Target
No Data
